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Abstract: Background: Complications of hypertensive disorders, during pregnancy (HDP), labour, postpartum have 
been recognized for centuries. Focus has shifted from maternal to materno-neonatal outcome, because effects of HDP 
on maternal metabolism have significant impact on perinatal outcome. Possibility of linkage of hyperinsulinemia leading 
to hypoglycaemia, growth retardation is real.  
Objective: Study was conducted to know relation of maternal serum insulin to the severity of hypertensive disorders and 
its effects on neonatal outcome.  
Material methods: Case control study was carried out over two years. Fasting blood sugar, insulin, post glucose blood 
sugar were estimated.  
Results: Overall 13.32% women who delivered during study period had HDP. Of these 964 women, 609(63.17%) had 
mild HDP, 12 (1.97%) of them had elevated insulin, 9 (75%) of 12 had LBW, [(2 neonatal deaths, 4(33.33%) still births, 
3(25%) admitted to neonatal intensive care NIC)]. Eighty three (8.6%) had severe HDP, 12(14.45%) of them had 
elevated serum insulin, 8 (66.33%) of 12 had LBW babies (2 NND, 2 still births, one admitted to NIC), significant 
(p<0.001) difference from 71 with severe HDP with normal insulin. One hundred eight (11.2%) had mild preeclampsia, 
21(19.44%) with elevated insulin, [17 (81%) of 21 had LBW babies, 4 (19.04%) NND, 3(14.28%) admitted to NIC, one 
(4.76%) septicemia. 9 (42.85%) still born, perinatal loss significantly higher (p<0.001), than 87 with mild preeclampsia 
and normal insulin. One hundred fifteen (11.9%) women had severe PE, 52(45.21%) had elevated serum insulin, 
16(30.76%) LBW babies, 13(25%) still births, 13 (25%) babies admitted to NIC, one of 13 (1.92%)died (LBW), difference 
(significant (p<0.05) from 63 severe PE with normal insulin. Fourty nine (5.08%) women had eclampsia, 24 (48.97%) of 
them had elevated insulin, of them 7 (29.16%) had LBW, 13(54.16%) still births, 13 (54.16%) admitted to NIC, one 
(4.16%) NND, significantly more than in 25 with normal insulin (p<0.02). In HDP maternal insulin levels correlated 
significantly with perinatal outcome irrespective of severity of HDP.  
Conclusion: While there was linkage of maternal serum insulin to the severity of HDP, the change in the insulin level 
affected the perinatal outcome more than the severity of HDP. 
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INTRODUCTION 
Hypertensive disorders of pregnancy (HDP) and 
their complications during pregnancy, labour, 
postpartum have been recognized for centuries, but 
“whys” remain poorly understood [1, 2]. There is now a 
growing body of evidence linking HDP with insulin 
resistance [3-7]. A high increase in blood glucose and 
insulin during pregnancy with HDP could lead to 
abnormalities of fetal weight, preterm delivery, neonatal 
hypoglycemia, septicemia and neonatal death [8-12]. 
All the women with HDP do not have FGR and low birth 
weight (LBW) babies but quite a few do have [13-15]. It 
is possible that, insulin plays a role. Looking at the 
significantly higher incidence of fetal growth restriction 
(FGR) among women with high insulin levels [16, 17], 
possibility of hyperinsulinemia leading to 
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OBJECTIVE 
Study was conducted to know the relationship of 
maternal serum Insulin levels on severity of 
hypertensive disorders of pregnancy effect on the 
neonatal outcome.  
MATERIAL AND METHODS 
The present case control study was carried out over 
a period of two years. Women with singleton pregnancy 
with gestational age more than 20 weeks and 
hypertensive disorders excluding chronic hypertension, 
pre-pregnancy diabetes, renal disease, coagulation 
disorders, epilepsy or any other major medical 
disorder, were included in the study, after taking 
informed written consent. Fasting blood sugar, insulin 
and post glucose blood sugar were estimated and 
repeated weekly. These women were followed up for 
maternal-neonatal outcome till delivery and 7 days 
postpartum, if the baby was admitted in Neonatal 
Intensive Care Unit (NICU) till the discharge of the 
baby. Still births (SB), LBW, neonatal deaths (NND), 
admission to the NICU and the indication for the 
admission were analyzed. 
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RESULTS 
During the study period of two years, there were 
7233 women delivered, 964 (13.32%) had HDP, [686 
(71.2%) rural, 278 (28.8 %) urban], rural significantly 
more than 60% overall rural (p<0.005), 58 (6%) were in 
their teens, significantly more than 4% overall teenage 
cases (P value <0.005), however majority of the 
women with HDP (768 (79.6%)) were of 20-24 years 
and 138 ≥ 25 yrs (13.1 %). Primigravida [777 (80.6 %)] 
were highly significantly more than overall 42% 
primigravida during the study period (P value <0.005). 
Of the 964 women, 634 (65.7 %) were term (≥ 37 
weeks) and 330 (34.30%) preterm (<37 weeks) at 
admission with HDP. 
Of the total 964 study subjects, 609(63.17%) had 
mild HDP, 12 (1.97%) of them had elevated serum 
insulin, 9 (75%) of these 12 had LBW babies, [2 NND, 
(one due to septicemia, one preterm), 4(33.33%) SB 
and 3(25%) babies were admitted to NICU] compared 
to 117 (19.5%) LBW babies, 10 (1.67%) stillbirths, 6 
(1%) NND and 21 (3.51%) admissions to NIC 
(p<0.001) amongst 597 cases of mild PIH with normal 
insulin levels. Among babies admitted to NIC, 28.57% 
died out of the cases with normal insulin levels 
compared to 66.66% NND amongst babies in NIC of 
the mothers with elevated insulin levels. 
Of all the study subjects, 83 (8.6%) had severe 
HDP, 12(14.45%) of them had elevated serum insulin. 
Eight (66.33%) of these 12 had LBW babies (2 NND 
and 2 SB, one baby was admitted to NIC, well on 
discharge), significant (p<0.001) difference from the 71 
women with severe PIH but normal insulin, 10 
(14.08%) LBW babies, 5(7.04%) NICU admissions and 
2 NND (2.81%). Among NICU admissions 2 NND 
occurred in babies of mothers with normal insulin but in 
the elevated serum insulin cases 2 NND occurred in 
the babies who didn’t get admitted to NIC at birth, 
suggesting that maternal insulin levels affected the 
babies’ health in the absence of other neonatal 
problems.  
Of the total 964 cases, 108 (11.2%) women had 
mild preeclampsia (PE), 21(19.44%) of them had 
elevated insulin. Of these 21 babies, 17 (81%) were 
LBW, 4 (19.04%) NND, 3(14.28%) admitted to NIC and 
one (4.76%) septicemia. 9(42.85%) SB (5 preterm), 
significantly higher (p<0.001) than 8 (9.2%) LBW 
babies, 8(9.2%) SB, 10 (1.5%) admissions to NICU, of 
which 2 (2.3%) NND amongst the 87 women with mild 
preeclampsia and normal insulin.  
One hundred fifteen (11.9%) women were of severe 
PE, 52(45.21%) of them had elevated serum insulin, 
16(30.76%) of them had LBW, 13(25%) SB, 13 (25%) 
babies were admitted to NICU and one (1.92%) NND 
(LBW) occurred, significantly more (p<0.05) than 63 
women with severe PE with normal insulin levels, 11 
(17.46%) SB, 14 (22.22%) LBW babies, (all preterm) 
and 8 babies (12.69%) were admitted to NICU, of 
which 7 (11.11%) died. 
Of the 964 cases with hypertensive disorders, 
49(5.08%) had eclampsia, 24 (48.97%) of them had 
elevated insulin. Of them 7 (29.16%) had LBW, 
13(54.16%) SB, 13 (54.16%) were admitted to NICU 
and one (4.16%) died. Of the 25 women of eclampsia 
with normal insulin, 6 (24%) had SB, 4(16%) LBW 
babies, 3(12%) NND occurred, 3(12%) were admitted 
to the NICU, later died, significant difference (P value 
<0.02). 
DISCUSSION 
Relationship between hyperinsulinemia and high 
blood pressure affecting maternal and feto-neonatal 
outcome has been reported [18-21]. In pregnancy, the 
alterations in the metabolism of carbohydrate and 
insulin may be playing a role in the etiogenesis and 
effects of hypertensive disorders of pregnancy. Many 
features of the insulin resistance syndrome have been 
associated with HDP, hyperinsulinemia, glucose 
intolerance, obesity, and lipid abnormalities [22-24]. 
The documentation of these features before the onset 
of hypertension in pregnancy suggests that insulin 
resistance or associated abnormalities may have a role 
in this disorder [25-27]. Insulin resistance is a 
physiologic phenomenon in normal pregnancy. In 
predisposed individuals this could lead to 
hyperinsulinemia with the development of gestational 
hypertension, gestational diabetes mellitus, or both. 
Elevated second-trimester insulin levels characterize 
the subsequent development of preeclampsia which 
supports the hypothesis that hyperinsulinemia and 
insulin resistance may contribute to the pathogenesis 
of preeclampsia [28]. Maternal mean blood-glucose 
and serum insulin in pregnancy correlated significantly 
with neonatal weight, It has been studied that maternal 
insulin sensitivity had stronger correlation with 
fetoplacental growth in comparison with maternal 
demographic or morphometric factors [29-31]. Whether 
the elevated insulin by way of causing hypoglycaemia 
leads to growth restriction or is it the higher insulin 
levels with severe disease that gives rise to higher 
percentage of LBW babies is not well understood. 
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In the present study of 609 women with mild PIH, 
12(1.64%) had hyperinsulinemia. Of 83 women with 
severe PIH, 12(17.39%) had elevated insulin levels. 
Twenty one (19.4%) of 108 women with mild PE had 
elevated insulin. Of 115 women with severe PE, 
52(45.2%) had elevated insulin and of 49 women with 
ecclampsia, 24(48.97%) had hyperinsulinemia. As the 
severity of HDP increased the derangements in the 
insulin increased, suggesting a positive relationship 
between the severity of the disease and serum 
hyperinsulinemia. Further to this elevation of insulin 
women with similar severity of HDP, the perinatal 
outcome was poorer in cases with hyperinsulinemia. 
Other researchers have also reported poor perinatal 
outcome in the women with HDP with elevated insulin 
levels compared to normal insulin levels in women with 
HDP [32, 33].  
Pregnancy is a physiological state which has 
significant alterations in glucose and insulin metabolism 
[34-36]. HDP affect maternal glucose metabolism, 
which further has impact on perinalal outcome [37]. 
Many factors play a role in the pathogenesis of FGR, 
including the maternal blood glucose level and serum 
insulin [38]. The principle modulator of this 
hyperinsulinemia in pregnancy is hyperoestroge- 
naemia.  
All women with hypertensive disorders do not have 
hyperinsulinemia and growth restriction. In the present 
study details of babies were recorded in mild and 
severe cases in relation to hyperinsulinemia. There 
was clear difference in cases with hyperinsulinemia, 
with similar severity of HDP. It was revealed that 
women with elevated insulin levels have a higher 
percentage of LBW babies and poorer perinatal 
outcome compared to women with normal insulin levels 
in women with similar severity of disease. Other 
researchers have also reported more perinatal deaths 
among women with hyperinsulinemia and suggested 
that more research is needed about carbohydrate 
metabolism in HDP for further understanding of the 
patho-physiology involved [39, 40]. 
In the present study of hypertensive disorders of the 
609 women with mild PIH, 12 had elevated insulin 
levels of whom one had preterm delivery, 3 were 
appropriate for gestational age (AGA), 3 had SB, 9 
were LBW, compared to 119 (19.5 %) FGR babies, 20 
(3.3 %) perinatal deaths. Of the 12 women with severe 
PIH and elevated insulin levels, 3 (25%) had FGR 
compared to 10 (14.49%) of 69 women with severe PIH 
with normal insulin levels. There were 12 (17.39%) 
perinatal deaths in women with severe PIH with 
elevated insulin compared to 7 of 14 (50%) neonatal 
deaths in the women with severe PIH with normal 
insulin levels. Of the 21 women with mild preeclampsia 
and elevated insulin levels, 6 (28.5 %) had FGR 
compared to 8 (9.2%) of the 87 of mild preeclampsia 
with normal insulin levels and perinatal deaths were 
14(16.09 %) compared 10 (11.49%) perinatal deaths 
among the women with HDP with normal insulin 
levels. Twenty two (35.4 %) of 62 women with severe 
preeclampsia and elevated insulin had FGR compared 
to 14 (26.4%) cases of FGR amongst of the 53 with 
severe preeclampsia with normal insulin. Thirteen 
(41.9%) of the 31 women with eclampsia with elevated 
insulin had FGR compared to 4 (22.2%) of the 18 
eclamptic women with normal insulin (P value <0.001). 
Researchers have also reported that alterations in 
glucose and insulin in pregnancy have critical impact 
on the birth outcome and later the growth of the 
offspring [41-43]. Perinatal outcome was affected by 
serum insulin in women with hypertensive disorders. 
There are not many studies from resource poor 
countries and more research is needed. 
CONCLUSION 
Perinatal outcome was affected by serum insulin in 
women with hypertensive disorders. While there was 
linkage of maternal serum insulin to the severity of 
HDP, the change in the insulin level affected the 
Table 1:  Severity of Hypertensive Disorders and Fasting Serum Insulin in Pregnant Women 
Insulin MPIH SPIH MPE SPE ECL 
Normal  597 71 87 63 25 
Elevated  12(1.64%) 12(17.39%) 21(19.4%) 52(45.21%) 24(48.97%) 
Total 609 83 108 115 49 
PIH- Pregnancy Induced Hypertension, MPIH=Mild PIH, SPIH=Severe PIH, MPE= Mild preeclampsia, SPE= Severe preeclampsia, ECL= 
Eclampsia 
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perinatal outcome more than the severity of HDP. 
There are not many studies from resource poor 
countries and more research is needed.  
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